HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 604 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $84,315,103 | -64.0% | 728,802 | -68.0% | 0.05% | -56.8% |
Q2 2023 | $234,494,606 | +8.1% | 2,279,967 | +14.7% | 0.12% | +3.3% |
Q1 2023 | $216,866,965 | -7.5% | 1,987,053 | -3.6% | 0.12% | -10.4% |
Q4 2022 | $234,558,073 | +95.5% | 2,061,143 | +6.3% | 0.14% | +87.5% |
Q3 2022 | $119,997,000 | -17.2% | 1,938,875 | +6.7% | 0.07% | -11.1% |
Q2 2022 | $144,910,000 | +21.5% | 1,816,832 | +60.3% | 0.08% | +44.6% |
Q1 2022 | $119,233,000 | +7.0% | 1,133,263 | +9.6% | 0.06% | +12.0% |
Q4 2021 | $111,475,000 | -8.3% | 1,034,467 | -6.8% | 0.05% | -13.8% |
Q3 2021 | $121,616,000 | +27.3% | 1,110,244 | +8.8% | 0.06% | +26.1% |
Q2 2021 | $95,547,000 | +14.5% | 1,020,355 | +12.6% | 0.05% | +2.2% |
Q1 2021 | $83,425,000 | +23.4% | 906,395 | -1.9% | 0.04% | +9.8% |
Q4 2020 | $67,586,000 | +1.6% | 923,937 | +7.9% | 0.04% | -10.9% |
Q3 2020 | $66,501,000 | +92.1% | 856,073 | +37.4% | 0.05% | +76.9% |
Q2 2020 | $34,617,000 | +331.8% | 622,842 | +130.1% | 0.03% | +271.4% |
Q1 2020 | $8,017,000 | +67.4% | 270,642 | +104.5% | 0.01% | +133.3% |
Q4 2019 | $4,789,000 | +31.7% | 132,335 | -0.9% | 0.00% | 0.0% |
Q3 2019 | $3,635,000 | -72.3% | 133,592 | -75.5% | 0.00% | -62.5% |
Q2 2019 | $13,103,000 | – | 544,676 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |